drugset / Trial / NCT03106766

Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females.

NCT03106766 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To assess facial acne vulgaris clinical and psychological outcomes by measuring differences in lesions counts, investigator global assessment, and subjects quality of life scores over 6 months in adult females treated with Next Science™ acne cream 2x or Next Science™ acne cream 1x in a double blind manner.

Timeline

Start
2017-03-27
Primary completion
2017-08-14
Completion
2017-08-14

Outcome

Outcome not reported

Stopped: “Decision from the Sponsor”

Drugs

EvaluationDrugModalityDoseRoute
Subject Acne cream 1X Unknown — —
Subject Acne cream 2X Unknown — Topical

Indications